GVHD is a common consequence of allogeneic bone marrow transplantation. Approximately 3 weeks following complete marrow eradication and the transplantation of allogeneic donor marrow cells, a cutaneous eruption is seen in up to 20% to 80% of patients, and may result in the death of the patient (1,2). The cutaneous manifestations may be the first indication of evolving GVHD.
KeywordsBone Marrow Transplantation Aplastic Anemia Lichen Planus Cutaneous Eruption Follow Bone Marrow Transplantation
Unable to display preview. Download preview PDF.
- 8.Storb R, Prentice RL, Buckner CD, Clift RA, Appelbaum F, Deeg J, Doney K, Hansen JA, Mason M, Sanders JE, Singer J, Sullivan KM, Witherspoon RP, Thomas ED. Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings: Beneficial effect of a protective environment. N Eng J Med 1983; 308: 302–307.CrossRefGoogle Scholar